Bows Pharmaceuticals AG
2 clinical trials · Sponsor
◉ Watch Bows Pharmaceuticals AG
| Record | Firm | Date |
|---|---|---|
| A Study to Determine the Absorption of Peroral Insulin in Dextran Matrix (ORA3) (NCT01114750) | Bows Pharmaceuticals AG | 2010-04-01 |
| A Two Part Study of Peroral Insulin in Type 2 Diabetes (NCT00990444) | Bows Pharmaceuticals AG | 2009-09-01 |
Track Bows Pharmaceuticals AG automatically
Every clearance here is in the API, with alerts when new ones post.